Thursday, June 24, 2021

mRNA startup Strand Therapeutics lands $52M to “program” new cancer therapies

  Messenger RNA brought the world its first Covid-19 vaccines, demonstrating along the way how this technology works. Strand Therapeutics is developing what could become the next generation of mRNA products: genetic circuits programmed with various features and functions, similar to the way writing computer code tells software how to execute multiple tasks. Already...

Priority Health to leverage data, partnerships for new social determinants initiative

Priority Health has launched a new data-driven social determinants of health initiative in collaboration with Socially Determined, ConsejoSano and Aunt Bertha. The Grand Rapids, Michigan-based health insurer plans to employ a “full lifecycle approach” to addressing social determinants of health, said Praveen Thadani, president of Priority Health, in an email. This means the insurer...

Scripps Health hit by 4 class-action lawsuits on heels of ransomware attack

Following a ransomware attack that disrupted its IT systems for nearly a month, Scripps Health is now facing four class-action lawsuits from patients for allegedly failing to protect their personal health information. In early May, the San Diego-based health system experienced a cybersecurity incident, which it later confirmed was a ransomware attack. In response,...

Mobile EHR startup DrChrono raises $12M, plans to build out telehealth features

  After launching a telehealth feature for its users earlier this year, health records startup DrChrono plans to build it out with $12 million in funding. The company recently raised a growth capital round led by ORIX Growth Capital, which led a debt financing for DrChrono last year.  After a challenging year for DrChrono’s...

Third Rock-backed Abata gets $95M to take cell therapy to MS, other autoimmune diseases

  Imagine an autoimmune disease treatment that activates only at the site of disease, shuts down inflammation from multiple sources, promotes tissue repair, and lasts for years. The source of this therapy, a type of immune cell, is already inside each and every one of us. Biotech startup Abata Therapeutics has raised $95 million...

Remote Patient Monitoring: Coming of age in an AI-driven world

Remote patient monitoring (RPM) is quickly establishing itself as one of the most effective tools for chronic disease management. RPM is the collection and transmission of patient health data to providers via connected devices outside of a conventional care setting. These monitoring devices record vital information, such as blood pressure, heart rate, or...

Register now for INVEST Digital Health September 21-23

The agenda for INVEST Digital Health, scheduled for September 21-23, reflects the diverse conversations happening in this sector, from AI to reimbursement to investment trends. Of course, digital health startups will take center stage with three tracks of the Pitch Perfect contest spanning Home Health, Chronic Disease Management and Value-based Care as well...

Pear Therapeutics plans to go public in $1.6B SPAC deal

With three FDA-cleared products on the market, and many more in its pipeline, Pear Therapeutics has solved one of the early puzzles of digital therapeutics: getting the green light from regulators for its software to be prescribed as a treatment. Now, the Boston-based startup is making plans to go public as it figures out...

5 Blues plans launch pharmacy solutions startup Evio

Five Blue Cross Blue Shield plans have joined forces to establish Evio, a new independent pharmacy solutions startup. The for-profit startup aims to rein in drug costs and improve clinical outcomes. The founding insurers, who invested the same undisclosed sum, are Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan, Blue...

uniQure updates lead gene therapy’s timeline; acquires Corlieve to feed pipeline

  A hemophilia B gene therapy that uniQure is testing in a pivotal clinical trial is on track for a filing with the FDA early next year, an updated timeline that follows discussions with the agency about the data needed to support a submission seeking regulatory approval. Netherlands-based uniQure said Tuesday that the FDA...
0FansLike
0FollowersFollow
- Advertisement -

Must Read